Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.36 USD | -2.06% | +11.91% | +177.41% |
May. 09 | Q32 Bio Inc. Provides Corporate Update | CI |
Apr. 11 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+177.41% | 362M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Homology Medicines Doses First Participant in HMI-103 Gene Editing Trial; Expects Initial Data From HMI-103, HMI-203 Trials in 2023